Preferred Content on Kadoorie

Some study content on this site is available in two formats. Please select how you'd prefer to view eligible content:

 General Public For individuals who are not healthcare or research professionals, including those with a personal interest in our work.
Healthcare Professionals For doctors, nurses, researchers and other professionals working in healthcare or clinical research.

Note: Not all studies have both formats. Your selection will apply only where alternative views are available.
Register Login

WHiTE 9

WHITE9_Logo_V4.0_23Jun2021_small.png
Comparing blood recycling during surgery with standard treatment for hip fracture

Theme

Hip Fracture

Body Part

Hip

Results expected in Spring 2026.

Around 65,000 people break their hip each year in England, Wales, and Northern Ireland, and almost all need surgery. About 6.5% of patients die within a month and 30% within a year, and many others experience a significant drop in quality of life. Most patients are older, frail, and often anaemic before surgery, which increases their risk of needing a blood transfusion. However, transfusions using donated blood can lead to infections and longer hospital stays. 
The WHiTE 9 study was a randomised controlled trial, looking to find out whether using cell salvage (where a patient’s own blood lost during surgery is collected, cleaned, and given back to them) reduced the need for donor blood, lowered infection risk, shortened recovery time, and/or improved outcomes for these patients.